ATE485048T1 - Pinienzapfenextrakte und ihre verwendung - Google Patents

Pinienzapfenextrakte und ihre verwendung

Info

Publication number
ATE485048T1
ATE485048T1 AT02773584T AT02773584T ATE485048T1 AT E485048 T1 ATE485048 T1 AT E485048T1 AT 02773584 T AT02773584 T AT 02773584T AT 02773584 T AT02773584 T AT 02773584T AT E485048 T1 ATE485048 T1 AT E485048T1
Authority
AT
Austria
Prior art keywords
pine cone
cone extract
cone extracts
useful
pine
Prior art date
Application number
AT02773584T
Other languages
English (en)
Inventor
Akiko Tanaka
John Jessip
William Guy Bradley
Original Assignee
Akiko Tanaka
John Jessip
William Guy Bradley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akiko Tanaka, John Jessip, William Guy Bradley filed Critical Akiko Tanaka
Application granted granted Critical
Publication of ATE485048T1 publication Critical patent/ATE485048T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
AT02773584T 2001-09-26 2002-09-26 Pinienzapfenextrakte und ihre verwendung ATE485048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/964,240 US6866875B2 (en) 2001-09-26 2001-09-26 Pine cone extracts and uses thereof
PCT/US2002/030489 WO2003026578A2 (en) 2001-09-26 2002-09-26 Pine cone extracts and uses thereof

Publications (1)

Publication Number Publication Date
ATE485048T1 true ATE485048T1 (de) 2010-11-15

Family

ID=25508302

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02773584T ATE485048T1 (de) 2001-09-26 2002-09-26 Pinienzapfenextrakte und ihre verwendung

Country Status (10)

Country Link
US (6) US6866875B2 (de)
EP (1) EP1438057B1 (de)
JP (1) JP4234594B2 (de)
CN (1) CN1596117A (de)
AT (1) ATE485048T1 (de)
AU (1) AU2002337697A1 (de)
DE (1) DE60238070D1 (de)
DK (1) DK1438057T3 (de)
ES (1) ES2354505T3 (de)
WO (1) WO2003026578A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
JPWO2006001364A1 (ja) * 2004-06-29 2008-04-24 株式会社 日本生薬研究所 ヒトパピローマウイルス疾患治療薬および抗ヒト免疫不全ウイルス薬
WO2009149264A2 (en) * 2008-06-04 2009-12-10 Allera Health Products, Inc. Anti-bacterial composition and method of using same
WO2013093438A1 (en) * 2011-12-23 2013-06-27 Sokerol Group Limited Liquid absorbent
KR101779981B1 (ko) 2017-05-02 2017-09-20 신승호 잣 솔방울 유 및 잣 솔방울 박을 포함하는 가축용 사료첨가제 및 그 제조방법
CN113829686B (zh) * 2021-09-18 2023-03-31 安徽农业大学 一种可降解聚合物基生物炭电磁屏蔽复合材料及制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1985249A (en) * 1933-05-25 1934-12-25 Harold E Sweet Watch bracelet
US3517052A (en) * 1966-07-06 1970-06-23 Cons Paper Bahamas Ltd Resins from bark
JPS60255733A (ja) 1984-05-30 1985-12-17 Nippon Beet Sugar Mfg Co Ltd β−Ｄ−グルカン
JPS62205032A (ja) 1986-03-04 1987-09-09 Hiroshi Sakagami 制癌剤
JPS63273458A (ja) * 1987-02-04 1988-11-10 Shinichiro Ozaki 松笠食品
JP2519461B2 (ja) * 1987-06-26 1996-07-31 宏 坂上 抗腫瘍性多糖
JP2594456B2 (ja) 1988-03-19 1997-03-26 宏 坂上 抗エイズウイルス剤
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
JP2522674B2 (ja) * 1987-09-17 1996-08-07 將純 ▲吉▼原 松の実の殻から生理活性物質を抽出する方法と、その抽出物を主原料とする抗感染症剤
JP2594453B2 (ja) * 1988-03-16 1997-03-26 正登 吉原 抗感染症剤
JP2782009B2 (ja) 1989-10-28 1998-07-30 靖一 田沼 リグニン配糖体およびその用途
JP2923660B2 (ja) 1990-01-06 1999-07-26 宏 坂上 ウイルス感染防止剤
JP2784605B2 (ja) 1990-04-28 1998-08-06 靖一 田沼 リグニン配糖体およびその用途
DE4017091A1 (de) * 1990-05-27 1991-11-28 Walter Dr Mach Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten
EP0565313B1 (de) * 1992-04-02 1997-07-30 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Verfahren zur Verbesserung des Geschmacks eines Fichtenextraktes und erhaltenes Produkt zur oralen Verwendung
US5413930A (en) * 1993-10-21 1995-05-09 Westvaco Corporation Method for regeneration of coniferous plants by somatic embryogenesis
JP3793593B2 (ja) * 1995-07-31 2006-07-05 中野 昌俊 抗ウィルス剤の製造方法
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
WO1998025633A2 (en) * 1996-12-09 1998-06-18 University Of Ghana Antiviral and antibacterial activities of extracts from eight plants
US20030078212A1 (en) 1998-10-30 2003-04-24 Jia-He Li Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
JP4183326B2 (ja) 1999-01-29 2008-11-19 中島 三博 ハナビラタケ抽出物
JP2001007290A (ja) * 1999-06-24 2001-01-12 Mitsubishi Electric Corp 半導体装置、半導体装置の製造方法、および、通信方法
CN1102066C (zh) * 1999-12-30 2003-02-26 辛耀禄 一种治疗艾滋病和肿瘤的药剂及其制备方法
JP2001240603A (ja) 2000-02-29 2001-09-04 Toei Shinyaku Kk β−１，３分岐β−１，６−グルカンとアガリクス茸アルカリ抽出エキス
JP2003040792A (ja) 2001-07-23 2003-02-13 West Park Kk リグニンの新規用途
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
US7025957B2 (en) * 2002-09-06 2006-04-11 Desert Whale Jojoba Company Composition and method to whiten skin

Also Published As

Publication number Publication date
JP4234594B2 (ja) 2009-03-04
US7338676B2 (en) 2008-03-04
CN1596117A (zh) 2005-03-16
US6866875B2 (en) 2005-03-15
EP1438057B1 (de) 2010-10-20
WO2003026578A3 (en) 2003-12-18
AU2002337697A1 (en) 2003-04-07
DE60238070D1 (de) 2010-12-02
WO2003026578A2 (en) 2003-04-03
US7838052B2 (en) 2010-11-23
ES2354505T3 (es) 2011-03-15
US20080226663A1 (en) 2008-09-18
US20060034955A1 (en) 2006-02-16
DK1438057T3 (da) 2011-02-07
JP2005508909A (ja) 2005-04-07
US20050158413A1 (en) 2005-07-21
US20030072826A1 (en) 2003-04-17
US20090142833A1 (en) 2009-06-04
EP1438057A4 (de) 2005-10-12
US7371417B2 (en) 2008-05-13
EP1438057A2 (de) 2004-07-21
HK1068275A1 (en) 2005-04-29
WO2003026578A9 (en) 2004-05-06
US20050153004A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
DK1517984T3 (da) Manuelt konstruktionsudstyr til tissue micro-array
WO2002083374A3 (en) Ceramic blade and production method therefor
WO2004031376A3 (en) Sesquiterpene synthases and methods of use
WO2004081205A8 (en) Differentiation of human embryonic stem cells to cardiomyocytes
DE10393377D2 (de) Herstellung von Suspensionen hydrophober Oxidpartikel
IL219266A (en) A method for producing a type I training response involving mature dendritic cells
ATE415966T1 (de) Substituierte 3-amino-thieno(2,3-b)pyridine-2- amide und herstellungsverfahren sowie deren verwendung
WO2005094230A3 (en) Hollow nanocrystals and method of making
WO2003006570A3 (en) Novel mesogens and methods for their synthesis and use
DK1543105T3 (da) Nye mutante stammer af pseudomonas fluorescens og varianter deraf, fremgangsmåde til deres fremstilling, og anvendelser deraf i alginatproduktion
WO2005024038A3 (en) Process for producing a capsular polysaccharide for use in conjugate vaccines
EP1921141A4 (de) Neues künstliches basenpaar und verwendung davon
ATE485048T1 (de) Pinienzapfenextrakte und ihre verwendung
WO2001079472A3 (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
WO2002033060A3 (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
EP1168918A4 (de) Impfstoff- und gentherapiezusammensetzungen und verfahren zu ihrer herstellung und verwendung
WO2002064666A3 (de) Polyphosphazen-haltige substrate als matrize und mit mikrostrukturierter oberfläche
EP1346972A4 (de) Verfahren zur herstellung von optisch aktiven halogenhydrinverbindungen
WO2003051927A3 (en) Production of f(ab')2 fragments in mammalian cells
WO2001085909A3 (en) Development of plant based biological sensors and novel disease resistance strategies
CO5950110A1 (es) Un metodo para la produccion de biomasa a partir de tejido diferenciado de la planta
HK1048135A1 (zh) 具增强细胞活力功能的高产量的细胞变动素(cytokine)
WO2000073420A3 (en) Creation of human tumorigenic cells and uses therefor
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
WO2002040645A3 (de) Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties